SEARCH

SEARCH BY CITATION

References

  • 1
    Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000; 32: 865871.
  • 2
    Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis 2002; 22: 4358.
  • 3
    Ferenci P, Lockwood AH, Mullen KD, Tarter RE, Weissenborn K, Blei AT et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716721.
  • 4
    Ortiz M, Cordoba J, Alonso J, Rovira A, Quiroga S, Jacas C, et al. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol 2004; 40: 552557.
  • 5
    Cordoba J, Sanpedro F, Alonso J, Rovira A. 1H-magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002; 17: 415429.
  • 6
    Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640644.
  • 7
    Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000; 32: 10351038.
  • 8
    Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598604.
  • 9
    Oppong KN, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotics pre-and post-liver transplantation: a psychometric and analyzed EEG study. HEPATOLOGY 1997; 26: 870876.
  • 10
    Ortiz M, Cordoba J, Jacas C, Flavia M, Esteban R, Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44: 104110.
  • 11
    Heaton RK, Grant I, Mathews CG. Comprehensive norms for an expanded Halstead-Reitan battery. Lutz, FL: Phsychological Assessment Resources, 1991.
  • 12
    Huizenga JR, Gips CH, Conn HO, Jansen PL. Determination of ammonia in ear-lobe capillary blood is an alternative to arterial blood ammonia. Clin Chim Acta 1995; 239: 6570.
  • 13
    Balata S, Damink SW, Ferguson K, Marshall I, Hayes PC, Deutz NE, et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. HEPATOLOGY 2003; 37: 931939.
  • 14
    Iwatani N, Inatomi Y, Yonehara T, Fujioka S, Hashimoto Y, Hirano T, et al. Portal vein thrombosis associated with hepatic encephalopathy. Rinsho Shinkeigaku 2005; 45: 235238.
  • 15
    Yamamoto T, Kuyama Y, Takeuchi K, Nagashima N, Honjo H, Sakurai N, et al. Hepatic encephalopathy due to portal vein thrombosis in a patient with pancreatic tumor. Pancreas 2003; 26: 313314.
  • 16
    Robin E, Lebrec D, Hammel P, Bernades P, Ruszniewski P. Hepatic encephalopathy after injection of lanreotide, a somatostatin analog. Gastroenterol Clin Biol 1996; 20: 10141016.
  • 17
    Ohnishi K, Saito M, Terabayashi H, Nomura F, Okuda K. Development of portal vein thrombosis complicating idiopathic portal hypertension. A case report. Gastroenterology 1985; 88: 10341040.
  • 18
    Yik KY, Sullivan SN, Troster M. Neuropsychiatric disturbance due to occult occlusion of the portal vein. Can Med Assoc J 1982; 126: 5052.
  • 19
    Warren WD, Millikan WJ Jr, Smith RB III, Rypins EB, Henderson JM, Salam AA, et al. Noncirrhotic portal vein thrombosis. Physiology before and after shunts. Ann Surg 1980; 192: 341349.
  • 20
    Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979; 48: 627639.
  • 21
    Fujii T, Kohno M, Hirayama C. Metabolism of 15N-ammonia in patients with cirrhosis: a three compartmental analysis. HEPATOLOGY 1992; 16: 347352.
  • 22
    Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol 2000; 15: 969979.
  • 23
    Voorhees AB Jr, Chaitman E, Schneider S, Nicholson JF, Kornfeld S, Price JB Jr. Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg 1973; 107: 659663.
  • 24
    Crespin J, Nemcek A, Rehkemper G, Blei AT. Intrahepatic portal-hepatic venous anastomosis: a portal-systemic shunt with neurological repercussions. Am J Gastroenterol 2000; 95: 15681571.
    Direct Link:
  • 25
    Weissenborn K, Ennen JC, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768773.
  • 26
    Amodio P, Marchetti P, Del Piccolo F, Campo G, Rizzo C, Iemmolo R, et al. Visual attention in cirrhotic patients: a study on covert visual attention orienting. HEPATOLOGY 1998; 27: 15171523.
  • 27
    Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 17: 2940.
  • 28
    Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. HEPATOLOGY 1993; 18: 10611068.
  • 29
    Nolte W, Wiltfang J, Schindler CG, Unterberg K, Finkenstaedt M, Niedmann PD, et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 1998; 29: 443449.
  • 30
    Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. HEPATOLOGY 1996; 24: 11161120.
  • 31
    Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weigthed MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993; 43: 6569.
  • 32
    Joebges EM, Heidemann M, Schimke N, Hecker H, Ennen JC, Weissenborn K. Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 2003; 38: 273280.
  • 33
    Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 1927.
  • 34
    Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 16101616.
  • 35
    Grossman RI, Gomori JM, Ramer KN, Lexa FJ, Schnall MD. Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics 1994; 14: 279290.
  • 36
    Shawcross DL, Balata S, Olde Damink SWM, Hayes PC, Wardlaw J, Marshall I, et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol 2004; 287: G503G509.
  • 37
    Weissenborn K. Minimal hepatic encephalopathy: a permanent source of discussion. HEPATOLOGY 2002; 35: 494496.
  • 38
    Groeneweg M, Quero JC, de Bruijn I, Hartmann IJ, Essink-Bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 4549.
  • 39
    Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691697.